Form 4 for INO INOVIO PHARMACEUTICALS, INC.
Accepted 2022-03-22 00:00:00 ET · period of report 2022-03-21 · accession 0001055726-22-000026 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-22 | 2022-03-21 | INO | Miller Ann Calby | Dir | M - OptEx | — | +4,273 | 29.5K | +17% | — |
| D | 2022-03-22 | 2022-03-21 | INO | Miller Ann Calby | Dir | M - OptEx | $0.00 | -4,273 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-21 | M | A | 4,273 | — | 29,534 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 12,821 restricted stock units is as follows: 4,274 shares vested on March 21, 2020; 4,274 shares vested on March 21, 2021; 4,273 shares vested on March 21, 2022. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |
| 2 | Derivative | Restricted Stock Unit | 2022-03-21 | M | D | 4,273 | $0.00 | 0 | D | — · — to — | 4,273 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 12,821 restricted stock units is as follows: 4,274 shares vested on March 21, 2020; 4,274 shares vested on March 21, 2021; 4,273 shares vested on March 21, 2022. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |